Fibraxis

0 followers

A new revolution in asthma care is on its way. We are developing a new, inhalable daily medication that halts and reverses the structural lung damage that occurs in asthma.

Employees

1-10

Links


Org chart

Rebecca Bignold
Chief Executive Officer
Collapse
No reports!

Teams

This company has no teams yet


Offices

This company has no offices yet